Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium 292

"Since T1D is an autoimmune disease, a likely strategy in the search for a cure seems to be modulation of the immune system. This book therefore brings together contributions from leaders in the arena of clinical immunotherapy, not limited to the diabetes field." Defining Optimal Immunotherapies For Type 1 Diabetes offers a comprehensive and up-to-date account of immunological strategies for preventing or treating T1D, and will be of particular interest to diabetologists and endocrinologists, both clinicians and researchers, as well as to immunologists and molecular or cell biologists and drug discovery scientists. The book also considers T1D within the broader context of autoimmune disease, and is therefore of interest to clinicians and researchers working on any such disease.